Can Jiang

1.2k total citations
31 papers, 630 citations indexed

About

Can Jiang is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Can Jiang has authored 31 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Can Jiang's work include Diabetes Treatment and Management (3 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Genomics and Diagnostics (2 papers). Can Jiang is often cited by papers focused on Diabetes Treatment and Management (3 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Genomics and Diagnostics (2 papers). Can Jiang collaborates with scholars based in China, United States and Japan. Can Jiang's co-authors include Yan Bi, Dalong Zhu, Wenhuan Feng, Xuehui Chu, Xitai Sun, Hongdong Wang, Wei-meng Zhao, Todd T. Kroll, Paul W. Huber and Pengzi Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Development.

In The Last Decade

Can Jiang

31 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Can Jiang China 13 226 155 130 114 102 31 630
Renpin Chen China 14 177 0.8× 87 0.6× 120 0.9× 112 1.0× 71 0.7× 27 505
Yusuke Kawauchi Japan 12 215 1.0× 177 1.1× 102 0.8× 258 2.3× 70 0.7× 21 691
Hongyu Zhao China 13 273 1.2× 212 1.4× 171 1.3× 63 0.6× 244 2.4× 34 840
Gonzalo Carrasco-Aviño Chile 15 266 1.2× 88 0.6× 185 1.4× 238 2.1× 69 0.7× 40 751
Agnieszka Adamek Poland 12 305 1.3× 57 0.4× 107 0.8× 217 1.9× 147 1.4× 33 767
Feng Shi China 15 370 1.6× 116 0.7× 260 2.0× 111 1.0× 116 1.1× 36 767
Ryoko Saito Japan 14 204 0.9× 106 0.7× 235 1.8× 67 0.6× 47 0.5× 77 685
Elisabeth Glitzner Austria 10 235 1.0× 191 1.2× 122 0.9× 41 0.4× 38 0.4× 12 681
Wei Xue China 15 207 0.9× 169 1.1× 172 1.3× 37 0.3× 57 0.6× 59 559
Karen Wallace United Kingdom 14 248 1.1× 87 0.6× 125 1.0× 337 3.0× 65 0.6× 23 907

Countries citing papers authored by Can Jiang

Since Specialization
Citations

This map shows the geographic impact of Can Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Jiang more than expected).

Fields of papers citing papers by Can Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Jiang. The network helps show where Can Jiang may publish in the future.

Co-authorship network of co-authors of Can Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Can Jiang. A scholar is included among the top collaborators of Can Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Jiang. Can Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Can, Renwei Feng, Yongqian Zhao, et al.. (2025). ITM2A as a potential prognostic marker for triple-negative breast cancer. Journal of Cancer. 16(9). 2903–2916. 1 indexed citations
2.
Zhang, Yuzhu, et al.. (2025). Metabolic reprogramming in cancer and senescence. MedComm. 6(3). e70055–e70055. 5 indexed citations
3.
Li, Qing, Yun Duan, Fuchen Jiang, et al.. (2024). 3D nanofiber sponge based on natural insect quaternized chitosan/pullulan/citric acid for accelerating wound healing. Carbohydrate Polymers. 348(Pt A). 122827–122827. 12 indexed citations
4.
Xu, Cheng, Jie Lu, Chenfeng He, et al.. (2024). Cytochrome P450 F3 promotes colorectal cancer via inhibiting NRF2-mediated ferroptosis. Translational Oncology. 48. 102077–102077. 3 indexed citations
6.
Chen, Zhuo, et al.. (2024). Chromosome-scale genome assembly of Docynia delavayi provides new insights into the α-farnesene biosynthesis. International Journal of Biological Macromolecules. 278(Pt 3). 134820–134820. 1 indexed citations
7.
Zhu, Ding, Xue Zhang, Yuan Fang, et al.. (2024). Identification of a lactylation-related gene signature as the novel biomarkers for early diagnosis of acute myocardial infarction. International Journal of Biological Macromolecules. 282(Pt 6). 137431–137431. 15 indexed citations
8.
Jiang, Bing‐Hua, et al.. (2023). Primary human thyrocytes maintained the function of thyroid hormone production and secretion in vitro. Journal of Endocrinological Investigation. 46(12). 2501–2512. 1 indexed citations
9.
Garman, Bradley, Can Jiang, Sherif Daouti, et al.. (2023). Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands. Frontiers in Immunology. 14. 1151748–1151748. 9 indexed citations
10.
Bian, Ning, Wenying Li, Hairui Li, et al.. (2023). Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation. Frontiers in Cardiovascular Medicine. 10. 1191539–1191539. 1 indexed citations
11.
Jiang, Can, Chun‐yang Zhang, Min Dai, et al.. (2023). Interplay between SUMO1-related SUMOylation and phosphorylation of p65 promotes hepatocellular carcinoma progression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(1). 119595–119595. 12 indexed citations
12.
Yan, Long, Wei Zhang, Xiaotong Hu, et al.. (2023). Association between breast nodules, anxiety, depression and metabolic risk factors in a Chinese cohort. Frontiers in Psychiatry. 14. 944354–944354. 1 indexed citations
13.
Feng, Wenhuan, Xuehui Chu, Xiaodong Shan, et al.. (2019). Metabolic effects and safety of Roux‐en‐Y gastric bypass surgery vs. conventional medication in obese Chinese patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 35(5). e3138–e3138. 20 indexed citations
14.
Wang, Hongdong, Lei Shen, Xitai Sun, et al.. (2019). Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity. Nature Communications. 10(1). 3254–3254. 79 indexed citations
15.
Yin, Tingting, Yan Bi, Ping Li, et al.. (2018). Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial. Nutrition & Metabolism. 15(1). 67–67. 16 indexed citations
16.
Zhang, Ting, et al.. (2018). Continuous positive airway pressure and oral appliances on treatment of obstructive sleep apnea hypopnea syndrome: A Meta-analysis. SHILAP Revista de lepidopterología. 43(7). 621–627. 1 indexed citations
17.
Feng, Wenhuan, Xitai Sun, Can Jiang, et al.. (2018). Type 1 innate lymphoid cells are associated with type 2 diabetes. Diabetes & Metabolism. 45(4). 341–346. 14 indexed citations
18.
19.
Yin, Tingting, Yan Bi, Ping Li, et al.. (2018). Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial. Diabetes Therapy. 9(3). 1253–1267. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026